Healthcare Reform
Our work in Healthcare Reform
-
Healthcare Delivery in California: Where Do We Go From Here?
On February 3, join Dana Goldman and Mark Ghaly, Secretary of the California Health and Human Services Agency, for a conversation on how California can deliver health care to everyone.Â
-
Development of High-Risk Geriatric Polypharmacy Electronic Clinical Quality Measures and a Pilot Test of EHR Nudges Based on These Measures
USC researchers developed measures of high-risk polypharmacy and pilot tested novel electronic health record (EHR)-based nudges grounded in behavioral science to promote deprescribing.
-
Comments on No Surprises Act Rulemaking: Part II
Loren Adler, Matthew Fiedler, and Benedic Ippolito offered comments on an interim final rule (IFR) issued by the Departments of Health and Human Services, Labor, and the Treasury that implements portions of the surprise billing provisions included in the No Surprises Act.
Categorized in USC-Brookings Schaeffer on Health Policy -
Targeting Affordability in Healthcare: A Review of the Evidence
Health plans have many tools to reduce spending and therefore reduce plan premiums, which can improve the affordability of health insurance.
-
How COVID Can Help Us Refocus on the How and Why of Value Assessment
The limitations of conventional approaches to value assessment are particularly clear when reflecting on our experience with the COVID-19 pandemic.
Categorized in Articles -
Economic Incentives for Administrative Simplification
In the US health care system, payers, health systems, physicians, other clinicians, drug companies, pharmacies, and pharmacy benefit managers all earn more revenue because of administrative complexity.
-
Patient and Physician Perspectives On Engaging in Palliative and Healthcare Trials: A Qualitative Descriptive Study
Researchers are encountering increasing challenges in recruiting participants for palliative and healthcare research. This paper aims to understand challenges to and methods for engaging physicians and seriously ill patients and their caregivers in research studies.
-
Private Equity Investment as a Divining Rod for Market Failure: Policy Responses to Harmful Physician Practice Acquisitions
It is unclear whether private equity investment is itself a problem or whether, in the absence of private equity, other sources of capital—such as public equity, venture capital, health systems, and insurers—would similarly exploit existing market failures and legal loopholes in the healthcare system.
-
Medical Device Regulation and Reimbursement: What the Pandemic Revealed
Join Schaeffer Center for a discussion on the challenges and opportunities facing the FDA and CMS in an age of breakthrough medical devices.
-
Medicare Coverage of Innovative Technologies: The U.S. Should do More to Speed Entry of Breakthrough Devices to Market
Equally pressing to FDA approval is the need to secure coverage from Medicare and Medicaid.
Categorized in Evidence Base